VITASPRING BIOMEDICAL CO., LTD. Operating Lease, Right-of-Use Asset, Amortization Expense
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $204.27 thousand for the 12-month period ending 2023-01-31, per its 10-K filed 2025-12-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2025-12-01
- VITASPRING BIOMEDICAL CO., LTD. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $204.27K.
- VITASPRING BIOMEDICAL CO., LTD. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $0.00.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|
| 2023-01-31 | $204.27K 10-K · filed 2025-12-01 |
| 2022-01-31 | $0.00 10-K · filed 2025-12-01 |